Co-culturing Glutamatergic Neurons and Pediatric High-Grade Glioma Cells

0 views • 4:27 min • July 8th, 2025

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Begin with a polymer-coated microfluidic device comprising reservoir wells connected by channels and filled with culture medium.

Remove the medium from the reservoirs and seed human induced pluripotent stem cells.

The cells enter the channels and adhere to the coated surface.

Now, fill the reservoirs with a differentiation medium.

Growth factors in the medium induce stem cell differentiation into neuronal progenitor cells.

Next, add a medium containing specific nutrients and neurotrophic factors that induce neuronal progenitor maturation into glutamatergic neurons.

These neurons release the excitatory neurotransmitter glutamate from their presynaptic terminals, which bind to postsynaptic neuron receptors, generating excitatory signals.

Now, take pediatric high-grade glioma cells, cancer cells derived from aggressive brain tumors.

Add the cells to the reservoirs and incubate. The glioma cells enter the channels and adhere.

Gradually, these cells form functional synapses with the glutamatergic neurons, facilitating neuronal-glioma cell crosstalk and leading to neuronal hyperactivity.

To begin culturing the commercialized human iPS-derived cortical glutamatergic neurons, empty the inlet and outlet reservoirs of the microfluidic device by pipette aspiration, letting only the device channels be filled with medium.

Seed the human iPS cells by adding 10 microliters of 6.5 million human iPS cells per milliliter suspension in the medium, and let the device be under the hood for 15 minutes to allow cells to attach. After 15 minutes, fill both inlet and outlet reservoirs with 50 microliters of day 4 culture medium. Then transfer the device into the incubator to maintain the cells at 37 degrees Celsius and 5% carbon dioxide for 23 days. Replace the medium every 3 to 4 days as described in the text.

To count the cells and assess viability using a standard phase contrast microscope, take microscopic pictures at 4th day, 21st day, and 23rd day. Culture both UW-479 and BT-35 cell lines in DMEM and F-12 glutamax supplemented with 10% fetal bovine serum in a cell culture flask. Maintain cell culture under a controlled environment at 37 degrees Celsius in normoxic conditions throughout the experiments. Observe each cell line to reach 80% confluency.

On day 21 post-culture of glutamatergic neurons, start co-culture by trypsinizing UW-479 and BT-35 cells. Seed the trypsinized UW-479 and BT-35 cells on top of the mature adherent glutamatergic neurons in each dedicated microfluidic device.

Maintain the co-cultures for two days under a controlled environment at 37 degrees Celsius and 5% carbon dioxide with glutamatergic neuron D11 and onward medium. Count pediatric high-grade glioma cells using the microscopic pictures, analyzed with the image analysis software to assess their viability and calculate the percentage of cells.

10:09

Migration, Chemo-Attraction, and Co-Culture Assays for Human Stem Cell-Derived Endothelial Cells and GABAergic Neurons

Related Videos

0 Views

07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Related Videos

0 Views

10:08

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions

Related Videos

0 Views

02:41

Assessing Glutamatergic Neurons and Glioma Cells Interactions in a Co-Culture

Related Videos

0 Views

12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Related Videos

0 Views

10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Related Videos

0 Views

08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Related Videos

0 Views

07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Related Videos

0 Views

11:02

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Related Videos

0 Views

07:44

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device

Related Videos

0 Views

Last updated: 27 June 2026